| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10965333 | Vaccine | 2015 | 9 Pages |
Abstract
This strain thus represents a promising candidate that merits further investigations and development. Our research also provides the proof of concept that selected ESX-1-complemented BCG strains may show low virulence and increased protective potential over parental strains.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Daria Bottai, Wafa Frigui, Simon Clark, Emma Rayner, Andrea Zelmer, Nuria Andreu, Marien I. de Jonge, Gregory J. Bancroft, Ann Williams, Priscille Brodin, Roland Brosch,